According to this evidence, the present study aimed to evaluate the interaction between the presence of PNPLA3 and TM6SF2 gene variants, T2D and IR with the presence of advanced fibrosis in a cohort of patients with NASH. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.